Dissertation > Excellent graduate degree dissertation topics show

To Researched the Impact of Rosuvastatin on Adiponectin, Visfatin and High Sensitivity C-reactive Protein in Patients with Metabolic Syndrome

Author: LiuPeng
Tutor: OuXiPing
School: Central South University
Course: Department of Cardiology
Keywords: Rosuvastatin calcium Metabolic syndrome adiponectin Visfatin High sensitivity C-reactive protein (hs-CRP)
CLC: R589
Type: Master's thesis
Year: 2011
Downloads: 44
Quote: 0
Read: Download Dissertation

Abstract


Objective:To observe the changes of adiponectin, visfatin, high sensitivity C-reactive protein(hs-CRP) in patients with metabolic syndrome and the impact of rosuvastatin on them. To discuss the impact of rosuvastatin on inflammatory factors in patients with metabolic syndrome.Methods:21 patients were enrolled in normal control group,53 patients with metabolic syndrome were randomly enrolled into test group (27 patients were taking rosuvastatin calcium, 10mg/night on the basis of conventional antihypertensive therapy) and control group (26 patients were taking conventional antihypertensive therapy), Seperately blood samples were taken Before or 4-6 weeks after treatment to investigate adiponectin, visfatin, hs-CRP.Results:1. Adiponectin:The adiponectines of before the test group and before and after the control group were lower than the normal control group, The differences between the groups were statistically significant (P<0.05); The test group test adiponectin was higher than before the test and the difference was statistically significant (P<0.05);The adiponectin of the test group was higher than the group 3 after the treatment and the difference was statistically significant (P<0.05) (the difference of before the two groupes was no statistically significant); The adiponectin after treatment in the control group was statistically different compared with the test group (P<0.05)2. Visfatin:The visfatin of test group and control group were higher than normal control group,both before and after experiment differences between the groups were statistically significant(P<0.05); Thet test group test visfatin was lower than before the test, the difference was statistically significant (P<0.05); The control group test visfatin was higher than before the test, the difference was statistically significant (P<0.05); The visfatin of the test group was lower than the control group after the treatment and the difference was statistically significant (P<0.05) (the difference of before the two groupes was no statistically significant); The visfatin after treatment in the control group was statistically different compared with the test group. (P<0.05)3. High sensitivity C-reactive protein (hs-CRP):The hs-CRP of the test group and the control group were higher than normal control group, both before and after experiment differences between the groups were statistically significant (P<0.05); The test group test hs-CRP was lower than before the test, the difference was statistically significant (P<0.05); The control group test hs-CRP was higher than before the test, the difference was statistically significant (P<0.05); The hs-CRP of the test group was lower than the control group after the treatment and the difference was statistically significant (P<0.05) (the difference of before the two groupes was no statistically significant); The hs-CRP after treatment in the control group was statistically different compared with the test group (P<0.05)4. Correlation analysis showed:Visfatin and body mass index (BMI) correlation coefficient was 0.449, P=0.016, statistically significant (P<0.05)Conclusion:1. The level of adiponectin significantly decreased in patients with metabolic syndrome,but high sensitivity C-reactive protein (hs-CRP) and visfatin significantly increased. 2. Visfatin and body mass index (BMI) were positively correlated with statistical significance (P<0.05)3. Rosuvastatin can make serum adiponectin levels significantly increased but make serum visfatin and high sensitivity C-reactive protein (hs-CRP) levels reduced in patients with metabolic syndrome, and there differences were statistically significant;The high sensitivity C-reactive protein was positively correlated trend with the visfatin but was negatively correlated trend with adiponectin.

Related Dissertations

  1. Study of Correlation between Serum Adiponectin Level and Arteriosteogenesis in Patients with Osteoporosis,R580
  2. The Expression of Visfatin in Liver of Rats in Different Glucose Metabolic Statuses and Effects to Glucose and Energy Metabolism,R587.1
  3. The Relationship of Serum Adiponectin、Nitric Oxide Synthase and Carotid Atherosclerosis in Patients with Acute Cerebral Infarction,R743.33
  4. Visfatin Enhances ICAM-1 and VCAM-1 Expression Under Lps Treatment in Rat Cadiocyte,R363
  5. Relationship between Carotid Atherosclerosis and C-reactive Protein, Leptin and Adiponectin in Patients with Metabolic Syndrome,R589
  6. The Changes and Influential Factors of Adiponectin、Apelin and Visfatin in Coronary Heart Disease Patients Accompanied with Abnormal Glucose Metabolism,R587.1
  7. Hyperglycemia in patients with metabolic syndrome and changes in coagulation and fibrinolysis system mechanism of rosiglitazone,R589
  8. The Effects and Machanism of Cholesterol Overload on Visfatin Secretion from Adipocytes,R589.2
  9. The Dynamic Variation of Serum Visfatin Level in Acute Coronary Syndrome Patients and Its Clinical Significance,R541.4
  10. Effects of A-SAA on the Expressions of Inflammatory Cytokines mRNA , Protein and Related Kinases of 3T3-L1 Adipocytes,R587.1
  11. Type 2 diabetes mellitus patients with hyperuricemia atherosclerosis and adiponectin , C-reactive protein in relation,R589.7
  12. The Relevance Research of Visfatin、 Insulin Resistance and the Structure and Function of Carotid Artery in Patients with Metabolic Syndrome,R589
  13. Association of Visfatin Gene Single Nucleotide Polymorphism (-1535C/T) and Plasma Levels with Type 2 Diabetes Mellitus in Ningxia Hui and Han Population,R587.1
  14. Studies on Chemical Constituents of Amomum Villasum Lour,R284
  15. Correlation of Serum Levels of hsCRP and vWF to the Degree and Stability of Coronary Artery Lesion in Patients with Coronary Heart Disease,R541.4
  16. Changes and Correlation of Visfatin and NT-proBNP in Patients with Thyroid Dysfunction,R581
  17. The Effect of Visfatin on Glucose-Lipid Metabolism in Liver,R587.1
  18. Study of Relationship between Vaspin, Adiponectin, Leptin and Diabetes Peripheral Neuropathy,R587.1
  19. Omentin-1 is Associated with Carotid Atherosclersois in Patients with Metabolic Syndrome,R589
  20. Relationship between Plasma N-terminal Pro-B-type Natriuretic Peptide Levels and Metabolic Syndrome,R589
  21. The Metabolic Syndrome Epidemic Situation and Relevant Factors of Xinjiang TaHe Oilfield Worker,R181.3

CLC: > Medicine, health > Internal Medicine > Endocrine diseases and metabolic diseases > Metabolic diseases
© 2012 www.DissertationTopic.Net  Mobile